Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
- Toyoaki Hida
- , Hiroshi Nokihara
- , Masashi Kondo
- , Young Hak Kim
- , Koichi Azuma
- , Takashi Seto
- , Yuichi Takiguchi
- , Makoto Nishio
- , Hiroshige Yoshioka
- , Fumio Imamura
- , Katsuyuki Hotta
- , Satoshi Watanabe
- , Koichi Goto
- , Miyako Satouchi
- , Toshiyuki Kozuki
- , Takehito Shukuya
- , Kazuhiko Nakagawa
- , Tetsuya Mitsudomi
- , Nobuyuki Yamamoto
- , Takashi Asakawa
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
874
リンクは新しいタブで開きます
被引用数
(Scopus)